应用
基因药物
Overview
疫苗
基因治疗
细胞治疗
疾病应用
Overview
肿瘤学
罕见疾病
传染病
载荷药物
Overview
mRNA
siRNA
质粒
小分子
蛋白和多肽
药物载体
Overview
脂质纳米粒
脂质体
聚合物纳米粒
产品
NxGen技术
仪器
Overview
NanoAssemblr® Spark™
NanoAssemblr® Ignite™ & Ignite+™
NanoAssemblr® Blaze™
NanoAssemblr® GMP System
可电离脂质试剂
Overview
GenVoy-ILM
GenVoy-ILM T Cell Kit for mRNA, Spark
GenVoy-ILM T Cell Kit for mRNA, Ignite
临床脂质纳米粒
服务
生物制药服务
合作伙伴
资源中心
市场活动
培训&学习
Overview
NanoMedU™课程
基因药物
纳米药物
知识中心
Overview
论文
视频中心
Application Notes
研讨会
文章报道
关于我们
公司介绍
新闻中心
招贤纳士
联系我们
EN
Search
x
Nanoparticle Manufacturing: Strategies for De-Risking Early Clinical Manufacture- Ray Lockard, Precision NanoSystems
Home
Resource Center
Videos & Webinars
Webinar
July 15, 2017
SHARE
Nanoparticle Manufacturing: Strategies for De-Risking Early Clinical Manufacture - Ray Lockard, Precision NanoSystems
limit search to this category
Advanced Search
All
Publications
Articles
Application Notes
Posters
Workshops
Videos & Webinars
Advanced Search
close
Publications
Application Notes
Posters
Workshops
Videos & Webinars
Articles
Search
Browse by Category
Application
Diagnostic and Imaging
Genetic Medicine
Hematology
Metabolic Disorders
Neuroscience
Oncology
Skeletal Disorders
Targeted Drug Delivery
Vaccines
Other Applications
Cell therapy
Formulation
Liposomes
Nucleic Acid Lipid Nanoparticles
Polymeric Nanoparticles
Other Formulations
Payload
DNA
microRNA
mRNA
siRNA
Small Molecule Drugs
Other Payloads